{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:07:31Z","timestamp":1762247251267,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.clinthera.2008.12.013","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T05:00:35Z","timestamp":1232686835000},"page":"2342-2353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacokinetics of 8-hour intravenous infusion of NXY-059: A phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers"],"prefix":"10.1016","volume":"30","author":[{"given":"Yi-Fang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingalill","family":"Reinholdsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"\u00c5senblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dag","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.12.013_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00004647-199907000-00008","article-title":"Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat","volume":"19","author":"Kuroda","year":"1999","journal-title":"J Cereb Blood Flow Metab."},{"key":"10.1016\/j.clinthera.2008.12.013_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bjp.0704449","article-title":"Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window","volume":"135","author":"Sydserff","year":"2002","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.clinthera.2008.12.013_bib3","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/01.STR.0000087790.79851.A8","article-title":"Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion","volume":"34","author":"Marshall","year":"2003","journal-title":"Stroke."},{"key":"10.1016\/j.clinthera.2008.12.013_bib4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1368-5031.2004.00245.x","article-title":"NXY-059: A neuroprotective agent in acute stroke","volume":"58","author":"Wang","year":"2004","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.clinthera.2008.12.013_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.STR.32.1.190","article-title":"NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species","volume":"32","author":"Marshall","year":"2001","journal-title":"Stroke."},{"key":"10.1016\/j.clinthera.2008.12.013_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMoa070240","article-title":"NXY-059 for the treatment of acute ischemic stroke","volume":"357","author":"Shuaib","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2008.12.013_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/jscd.2002.123973","article-title":"Pharmacokinetics of NXY-059, a nitrone-based free radical trapping agent, in healthy young and elderly subjects","volume":"11","author":"Edenius","year":"2002","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"10.1016\/j.clinthera.2008.12.013_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00228-002-0478-x","article-title":"Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke","volume":"58","author":"Strid","year":"2002","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2008.12.013_bib9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1185\/030079906X121075","article-title":"Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects","volume":"22","author":"Wemer","year":"2006","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.clinthera.2008.12.013_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.STR.0000053032.14223.81","article-title":"Tolerability of NXY-059 at higher target concentrations in patients with acute stroke","volume":"34","author":"Lees","year":"2003","journal-title":"Stroke."},{"key":"10.1016\/j.clinthera.2008.12.013_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1152\/physrev.1993.73.4.765","article-title":"Mechanisms mediating renal secretion of organic anions and cations","volume":"73","author":"Pritchard","year":"1993","journal-title":"Physiol Rev."},{"key":"10.1016\/j.clinthera.2008.12.013_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002329900247","article-title":"Renal transporters for organic anions and organic cations. Structural requirements for substrates","volume":"158","author":"Ullrich","year":"1997","journal-title":"J Membr Biol."},{"key":"10.1016\/j.clinthera.2008.12.013_bib13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/0091270007301803","article-title":"Active renal secretion of NXY-059, a novel neuroprotectant, is mediated via an organic acid transporter","volume":"47","author":"Cheng","year":"2007","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2008.12.013_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/clpt.1993.182","article-title":"Ethnic differences in response to morphine","volume":"54","author":"Zhou","year":"1993","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2008.12.013_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron."},{"key":"10.1016\/j.clinthera.2008.12.013_bib16","first-page":"391","article-title":"Uber den Niederschlag welchen Pikrins\u00e4ure in normalem Harn erzeugt und ueber eine neue Reaction des Kreatinins","volume":"10","author":"Jaff\u00e9","year":"1886","journal-title":"Z Physiol Chem."},{"key":"10.1016\/j.clinthera.2008.12.013_bib17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2165\/00003088-200544080-00007","article-title":"Population pharmacokinetic modelling and estimation of dosing strategy for NXY-059, a nitrone being developed for stroke","volume":"44","author":"J\u00f6nsson","year":"2005","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.clinthera.2008.12.013_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/009286159502900324","article-title":"Assessment of dose proportionality: Report from the statisticians in the Pharmaceutical Industry\/Pharmacokinetics UK Joint Working Party","volume":"29","author":"Gough","year":"1995","journal-title":"Drug Inf J."},{"key":"10.1016\/j.clinthera.2008.12.013_bib19","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1185\/030079907X210679","article-title":"A phase 1, placebo-controlled, randomised, double-blind (within dose panels) study evaluating the safety, tolerability and pharmacokinetics of intravenous NXY-059 in Japanese subjects","volume":"23","author":"Watabe","year":"2007","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.clinthera.2008.12.013_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.STR.32.3.675","article-title":"Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke","volume":"32","author":"Lees","year":"2001","journal-title":"Stroke."},{"key":"10.1016\/j.clinthera.2008.12.013_bib21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1177\/0091270004268128","article-title":"Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms","volume":"44","author":"Kim","year":"2004","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2008.12.013_bib22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/j.1552-4604.1997.tb05632.x","article-title":"Pharmacokinetics of fosinoprilat in Chinese and whites after intravenous administration","volume":"37","author":"Hu","year":"1997","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2008.12.013_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00008571-200309000-00007","article-title":"Estimating the contribution of genes and environment to variation in renal drug clearance","volume":"13","author":"Leabman","year":"2003","journal-title":"Pharmacogenetics."},{"key":"10.1016\/j.clinthera.2008.12.013_bib24","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.clinthera.2008.12.013_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2710.2000.00281.x","article-title":"Pharmacogenetics and psychopharmacotherapy","volume":"25","author":"Poolsup","year":"2000","journal-title":"J Clin Pharm Ther."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:02:43Z","timestamp":1762246963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808004396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0149291808004396"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.013","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of 8-hour intravenous infusion of NXY-059: A phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Excerpta Medica Inc. All rights reserved. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}